ArticleOncoimmunology

Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer.

Armin Jarosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.